VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

CAR-T Meeting 2020 | Building a Swiss timepiece: CAR T-cell industrial manufacturing

Dorothea Ledergerber, PhD, Novartis, Stein, Switzerland, tells us how Novartis opened a new manufacturing facility for cell and gene therapies in just a year. Dr Ledergerber outlines the challenges faced in CAR T-cells manufacture, in particular, the turnaround time. This interview took place at the 2nd European CAR T-Cell Meeting in Sitges, Spain.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter